ABD56 causes osteoclast apoptosis by inhibiting the NFkappaB and ERK pathways

Aymen I Idris, Aymen Idris, Emanuela Mrak, Iain Greig, Francesca Guidobono, Stuart H Ralston, Rob van 't Hof

Research output: Contribution to journalArticlepeer-review


We have previously shown that the biphenylcarboxylic acid butanediol ester (ABD56) inhibits osteoclast formation and activity in vitro and in vivo. However, the mechanism of action of this compound is unknown. ABD56 inhibited osteoclast formation and caused osteoclast apoptosis, but had no effects on osteoblasts or macrophages. As the NFkappaB and MAPK pathways are essential for osteoclast formation and survival, we studied the effects of ABD56 on these pathways. ABD56 caused phosphorylation of p38, JNK and nuclear translocation of c-jun in osteoclasts. ABD56-induced apoptosis was prevented by the caspase inhibitor zVAD-fmk but was not prevented by the p38- or JNK-inhibitors. ABD56 completely abolished RANKL-induced IkappaB and ERK1/2 phosphorylation. Increasing the amount of RANKL partially rescued ABD56-induced apoptosis, indicating that the apoptosis is most probably due to the inhibition of survival signals such as ERK and NFkappaB, rather than activation of the p38 or Jnk MAPK pathways.
Original languageEnglish
Pages (from-to)94-8
Number of pages5
JournalBiochemical and Biophysical Research Communications
Issue number1
Publication statusPublished - 2008


  • Amino Acid Chloromethyl Ketones
  • Animals
  • Apoptosis
  • Benzoates
  • Biphenyl Compounds
  • Caspases
  • Cells, Cultured
  • Cysteine Proteinase Inhibitors
  • Extracellular Signal-Regulated MAP Kinases
  • Mice
  • NF-kappa B
  • Osteoclasts
  • Phosphorylation
  • RANK Ligand
  • Rabbits
  • Signal Transduction


Dive into the research topics of 'ABD56 causes osteoclast apoptosis by inhibiting the NFkappaB and ERK pathways'. Together they form a unique fingerprint.

Cite this